Skip to Main Content

Paper Details

IL-13 is a driver of COVID-19 severity.
medRxiv
16
2021
CD44, COVID-19, Has1, IL-13, Immune dysregulation, L-13, SARS, SARS-CoV-2, SARS-CoV-2 infection, anti-IL-13, gene, hyaluronan synthase 1, interleukin-13, lung disease, mice, mouse, patient, patients, pulmonary diseases
Author NameAffiliation
Alexandra N DonlanUniversity of Virginia School of Medicine
Alexandra N DonlanUniversity of Virginia School of Medicine
Tara E SutherlandLydia Becker Institute of Immunology and Inflammation, University of Manchester
Chelsea MarieUniversity of Virginia School of Medicine
Saskia PreissnerCharite - Universitatsmedizin Berlin, Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Benjamin T BradleyUniversity of Washington
Rebecca M CarpenterUniversity of Virginia School of Medicine
Jeffrey M SturekUniversity of Virginia School of Medicine
Jennie Z MaUniversity of Virginia School of Medicine
Gregory Brett MoreauUniversity of Virginia School of Medicine
Jeffrey R DonowitzUniversity of Virginia School of Medicine
Jeffrey R DonowitzChildren's Hospital of Richmond, Virginia Commonwealth University
Gregory A BuckVirginia Commonwealth University
Myrna G SerranoVirginia Commonwealth University
Stacey L BurgessUniversity of Virginia School of Medicine
Mayuresh M AbhyankarUniversity of Virginia School of Medicine
Cameron MuraSchool of Data Science and Department of Biomedical Engineering University of Virginia
Philip E BourneSchool of Data Science and Department of Biomedical Engineering University of Virginia
Philip E BourneSchool of Data Science and Department of Biomedical Engineering University of Virginia
Robert PreissnerScience-IT and Institute of Physiology, Charite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health
Mary K YoungUniversity of Virginia School of Medicine
Genevieve R LyonsUniversity of Virginia School of Medicine
Johanna LoombaIntegrated Translational Health Research Institute (iTHRIV), University of Virginia School of Medicine
Sarah J Ratcliffe (CM4AI)University of Virginia School of Medicine
Melinda D PoulterDepartment of Pathology University of Virginia School of Medicine
Amy J MathersUniversity of Virginia School of Medicine
Amy J MathersDepartment of Pathology University of Virginia School of Medicine
Agnes A DayLydia Becker Institute of Immunology and Inflammation, University of Manchester
Agnes A DayUniversity of Manchester
Barbara J MannUniversity of Virginia School of Medicine
Judith E AllenLydia Becker Institute of Immunology and Inflammation, University of Manchester
Judith E AllenUniversity of Manchester
William A PetriUniversity of Virginia School of Medicine
William A PetriUniversity of Virginia School of Medicine
William A PetriDepartment of Pathology University of Virginia School of Medicine
  • 1 - 35

Datasets